On Oct. 22, Law360 published an article titled “OIG Remains Focused On Pharmaceutical Copayment Coupons” by Ropes & Gray health care partner Eve Brunts (Boston). The article provides pharmaceutical manufacturers and pharmacies with insight regarding the recent U.S. Department of Health and Human Services' Office of Inspector General
—report and special advisory bulletin on the use of copayment coupons by pharmaceutical manufacturers to reduce or eliminate immediate out-of-pocket costs for specific prescription drugs.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.